Can We Use B-type Natriuretic Peptides to Monitor Patients with Heart Failure?

Q: What is the clinical evidence from this study?

Study design: Review. Population: Heart failure. Intervention: B-type natriuretic peptides (BNPs) monitoring.

Theresa A. McDonagh; Roy S. Gardner; Kwok S. Chong; Henry J. Dargie

doi:10.2217/17520363.1.3.349

October 1, 2007Biomarkers in Medicine

Can We Use B-type Natriuretic Peptides to Monitor Patients with Heart Failure?

View at Publisher

Ask AI

Bookmark

Share

Key result

This review summarizes the existing evidence for and against the use of B-type natriuretic peptides (BNPs) to monitor therapy in patients with heart failure.

Why the study?

Can B-type natriuretic peptides (BNPs) be used to monitor therapy in patients with heart failure?

Key Points

To review the existing clinical evidence for and against the use of B-type natriuretic peptides for monitoring therapy in heart failure.
Reviewed published literature on the established diagnostic and prognostic utility of B-type natriuretic peptides and evaluated evidence surrounding their role in therapy guidance.
B-type natriuretic peptides maintain a well-documented and validated role in diagnosing heart failure and determining patient prognosis.
The clinical utility of using B-type natriuretic peptide levels to routinely monitor and adjust heart failure therapy remains less defined, with evidence presenting both supportive and opposing arguments.

Structured PICO

Can B-type natriuretic peptides (BNPs) be used to monitor therapy in patients with heart failure?

P

Population

Patients with heart failure

I

Intervention

B-type natriuretic peptides (BNPs) for therapy monitoring

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

This review summarizes the evidence regarding the potential role of B-type natriuretic peptides (BNPs) for monitoring therapy in patients with heart failure.

Abstract

The B-type natriuretic peptides (BNPs) now have a well-established role in the diagnosis of heart failure. There is also a wealth of evidence on their ability as prognostic markers in patients with heart failure. The other potential role of BNPs is in the arena of therapy monitoring, although much less is known regarding this putative application. This review summarizes what evidence there is both for and against using BNPs to monitor heart failure patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

McDonagh et al. (2007) conducted a review in Heart failure. B-type natriuretic peptides (BNPs) monitoring was evaluated. This review summarizes the existing evidence for and against the use of B-type natriuretic peptides (BNPs) to monitor therapy in patients with heart failure.

synapsesocial.com/papers/6a9cbe6e898667d1a5f7c3d5 https://doi.org/10.2217/17520363.1.3.349

View at Publisher

Ask AI

Bookmark

Share

Can We Use B-type Natriuretic Peptides to Monitor Patients with Heart Failure?

Key Points

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Can We Use B-type Natriuretic Peptides to Monitor Patients with Heart Failure?

Key Points

Structured PICO

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading